REEMF
RARE ELEMENT RESOURCES LTD
$0.5450
-9.17%
No data for this timeframe.
Vol
Insider Activity2B / 0S
Insider Net $$4814.3T
Recent Activity
May 19, 2026
earnings_calendar
REEMF Q1 2026 Earnings Scheduled — 2026-05-19
Mar 10, 2026
Insider
Synchron bought 100,149,060 shares
10%+ Owner @ $24,035,774.40 ($2407.2T)
Mar 10, 2026
Insider
BLUE JAMES N bought 100,149,060 shares
10%+ Owner @ $24,035,774.40 ($2407.2T)
Mar 4, 2026
Insider
Grandey Gerald W sold 1,250,000 shares
Director @ $0.2400 ($300.0K)
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Mar 10, 2026 | Synchron | BUY | $2407.2T |
| Mar 10, 2026 | BLUE JAMES | BUY | $2407.2T |
| Mar 4, 2026 | Grandey Gerald | A | $300.0K |
| Mar 4, 2026 | HICKEY PAUL | A | $1.5K |
| Mar 4, 2026 | HICKEY PAUL | A | $1.7K |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
4 unique insiders with 2 transactions. Net insider value: $4814.3T ($4814.3T bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | Synchron | 10%+ Owner | BUY | 100,149,060 | $24,035,774.40 | $2407.2T |
| Mar 10, 2026 | BLUE JAMES N | 10%+ Owner | BUY | 100,149,060 | $24,035,774.40 | $2407.2T |
| Mar 4, 2026 | Grandey Gerald W | Director | A | 1,250,000 | $0.2400 | $300.0K |
| Mar 4, 2026 | HICKEY PAUL JOSEPH | Director | A | 6,250 | $0.2400 | $1.5K |
| Mar 4, 2026 | HICKEY PAUL JOSEPH | Director | A | 6,940 | $0.2400 | $1.7K |
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q 2015-09-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2015-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 19, 2026
earnings_calendar
REEMF Q1 2026 Earnings Scheduled — 2026-05-19
Apr 8, 2026
Clinical Trial
Withdrawal of Tiratricol Treatment in Males With Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
Phase Phase 3 — COMPLETED
Mar 23, 2026
earnings_calendar
REEMF Q4 2025 Earnings Scheduled — 2026-03-23